Bourgoin S, Artaud F, Cesselin F, Glowinski J, Hamon M
Brain Res. 1985 Dec 30;361(1-2):361-72. doi: 10.1016/0006-8993(85)91306-x.
The possible influence of GABAergic systems on the activity of enkephalinergic neurones within the basal ganglia was examined by measuring the release of Met-enkephalin in the caudate nuclei and pallida of halothane-anesthesized cats treated by intra-caudate applications of GABA-related drugs. Depending on the concentration used, GABA exerted local stimulatory (at 10 microM of the amino acid) or inhibitory (at 0.5 mM) action on Met-enkephalin release in the cat caudate nucleus. Only the inhibition was reproduced by the GABA agonists muscimol (1 microM) and (-)-balcofen(10 microM) and by diazepam 10 microM). Conversely, the intra-caudate application of the GABA antagonist bicuculline enhanced markedly the local release of the pentapeptide. Complementary studies using slices of the rat striatum (caudate nucleus + putamen) revealed that a low concentration of GABA (10 microM) tended to increase the K+-evoked efflux of Met-enkephalin, whereas a high concentration of the amino acid exerted a strong inhibitory effect on the peptide release. Such in vivo and in vitro findings suggest that the GABA-induced inhibition of Met-enkephalin release took place via the stimulation of specific GABA A and GABA B receptors within the caudate nucleus, whereas the GABA-induced increase of the peptide release might involve some intracellular regulatory processes in striatal neurones containing both GABA and enkephalins. In addition to altering the local release of Met-enkephalin, intra-caudate applications of GABA-related drugs affected the peptide release in the ipsilateral globus pallidus and contralateral basal ganglia. The observed changes suggest that GABA A, but not GABA B, receptors participated in some tonic inhibitory influence of striatal GABAergic neurones on the striato-pallidal enkephalinergic system. Furthermore, the present results confirmed previous studies (Bourgoin et al.) showing that GABAergic neurones can contribute to some bilateral modulation of enkephalinergic neurones within the basal ganglia.
通过测量在尾状核内注射GABA相关药物的氟烷麻醉猫的尾状核和苍白球中蛋氨酸脑啡肽的释放,研究了GABA能系统对基底神经节内脑啡肽能神经元活性的可能影响。根据所使用的浓度,GABA对猫尾状核中蛋氨酸脑啡肽的释放产生局部刺激作用(氨基酸浓度为10微摩尔)或抑制作用(浓度为0.5毫摩尔)。只有GABA激动剂蝇蕈醇(1微摩尔)、(-)-巴氯芬(10微摩尔)和地西泮(10微摩尔)能重现这种抑制作用。相反,尾状核内注射GABA拮抗剂荷包牡丹碱可显著增强五肽的局部释放。使用大鼠纹状体(尾状核+壳核)切片的补充研究表明,低浓度的GABA(10微摩尔)倾向于增加钾离子诱发的蛋氨酸脑啡肽外流,而高浓度的氨基酸对肽释放有强烈的抑制作用。这种体内和体外研究结果表明,GABA诱导的蛋氨酸脑啡肽释放抑制是通过刺激尾状核内特定的GABA A和GABA B受体发生的,而GABA诱导的肽释放增加可能涉及含有GABA和脑啡肽的纹状体神经元中的一些细胞内调节过程。除了改变蛋氨酸脑啡肽的局部释放外,尾状核内注射GABA相关药物还影响同侧苍白球和对侧基底神经节中的肽释放。观察到的变化表明,GABA A受体而非GABA B受体参与了纹状体GABA能神经元对纹状体-苍白球脑啡肽能系统的一些紧张性抑制作用。此外,本研究结果证实了先前的研究(布尔古安等人)表明,GABA能神经元可参与基底神经节内脑啡肽能神经元的一些双侧调节。